GIA
GOSS icon

Gladstone Institutional Advisory’s Gossamer Bio GOSS Stock Holding History

Gladstone Institutional Advisory’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.11K Hold
24,955
– – ﹤0.01% 892
2026
Q1 		$8.2K Buy
24,955
+10,785
+76% +$17K ﹤0.01% 829
2025
Q4 		$43.9K Buy
+14,170
New +$40.4K ﹤0.01% 782

Other funds holding GOSS

CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
WA
Waddell & Associates Memphis, Tennessee $2.02B AUM 36.49% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
SCP
Sivia Capital Partners Mill Valley, California $822M AUM 48.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CG
Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Gladstone Institutional Advisory's GOSS Position: Q2 2026 in Review

Gladstone Institutional Advisory held its Gossamer Bio (GOSS) position steady in Q2 2026 at 24,955 shares worth $4.11K. The position accounts for ﹤0.01% of the portfolio, ranked #892.

Gladstone Institutional Advisory first reported a position in GOSS in Q4 2025 and has held it in 3 quarters since. The position peaked at $43.9K in Q4 2025. 32 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Gladstone Institutional Advisory held 24,955 shares of Gossamer Bio worth $4.11K as of Q2 2026.
  • Gladstone Institutional Advisory left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #892 holding.
  • Gladstone Institutional Advisory first reported a position in Gossamer Bio in Q4 2025 and has held it in 3 quarters since.
  • Gladstone Institutional Advisory's Gossamer Bio position peaked at $43.9K in Q4 2025.
  • 32 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.